REG - MyHealthChecked PLC - Directorate Change

MyhealthcheckedAnnouncement

06/04/2021 14:35

RNS Number : 5461U
  
MyHealthChecked PLC
  
06 April 2021
  
 

MyHealthChecked plc
("MyHealthChecked" or "the Company")
 
Directorate Change
 
MyHealthChecked plc (AIM: MHC), the consumer home-testing healthcare company, announces that Peter Dines, Non-executive Director, has today stepped down from the Board. Peter is Chief Operating Officer at Mercia Asset Management PLC1 ("Mercia") and is standing down to focus on other portfolio companies.
 
The Directorate change follows on from the successful roll-out of a new corporate strategy for growth in 2021 and beyond, which has seen MyHealthChecked focus on bringing further simple, reliable, affordable health tests to market.
 
Peter Dines commented: "Having been associated with the Company prior to the public listing and living through the evolution of the senior management team in recent years, I am delighted that under Penny's leadership the company is now well placed to execute its new strategy and deliver further growth.  The news today announcing the agreement with Boots is a natural time to step down in order to focus on other portfolio activities and I wish the company continued success for the future."
 
Adam Reynolds, Non-executive Chairman of MyHealthChecked, said: "We are incredibly grateful for the support provided by Peter and we have benefitted enormously from his experience of commercialising and scaling exciting medtech companies. We continue to benefit from the support of Mercia, as our largest shareholder, including their participation in our most recent fundraising which will fuel the next exciting stage of our growth and evolution as we seek to become the UK's leading business-to-consumer testing business." 
 
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The Directors of the Company take responsibility for this announcement.
 
For further information please contact:
 



MyHealthChecked plc


www.myhealthcheckedplc.com




Penny McCormick, Chief Executive Officer


via Walbrook PR




Maddy Kennedy, Chief Financial Officer


















SPARK Advisory Partners Limited (NOMAD)


Tel: +44 (0)20 3368 3550




Neil Baldwin


















Oberon Investments (Broker)


Tel: +44 (0)203 179 5344




Mike Seabrook


mikeseabrook@oberoninvestments.com














Walbrook PR Ltd (Media & IR)


Tel: +44 (0)20 7933 8780 or myhealthchecked@walbrookpr.com




Paul McManus


Mob: +44(0)7980 541 893




Alice Woodings


Mob: +44(0)7407 804 654








 
 




 
About MyHealthChecked PLC (www.myhealthcheckedplc.com) 
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company with two diverse, customer-facing at-home testing brands in its portfolio:
 
MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests, now in development following the recent acquisition of The Genome Store. The tests will be made available online, and would be viable for over the counter purchase. 
 
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.
 
Mylo targets the personalized mobile health market, with a primary focus on hormone testing and increasing a woman's chances of naturally getting pregnant, by enabling her to quantitively track her levels of luteinizing hormone (LH) prior to ovulation.
 
1Mercia Asset Management PLC is the ultimate parent company of Mercia (General Partner) Limited as general partner of Mercia Investment Plan LP ("Mercia GP"), and of the fund managers of both the Mercia EIS Funds ("Mercia EIS") and Enterprise Ventures (General Partner FY Seedcorn) Limited as general partner of Finance Yorkshire Seedcorn LP ("FYSC"). Together, Mercia GP, Mercia EIS and FYSC own 205,764,327 shares, representing c28.4% of the current issued share capital of the Company.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
BOAZZGGDFVNGMZM